Medtronic MDT Ratios & Valuation
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 260.7%-0.3pp | 261%-0.4pp | 261.4%+0.5pp | 260.9%+0.1pp | 260.8%0.0pp | |
| Operating margin | 70.6%0.0pp | 70.5%+0.2pp | 70.3%+1.5pp | 68.8%+2.1pp | 66.8%+1.9pp | |
| Net margin | 53.5%-0.7pp | 54.2%+0.2pp | 54.1%+0.7pp | 53.4%+1.6pp | 51.8%+2.5pp | |
| Returns | ||||||
| Return on equity | 38.8%+0.4pp | 38.4%+1.0pp | 37.4%+1.2pp | 36.2%+1.8pp | 34.4%+2.3pp | |
| Return on invested capital | 27%+0.1pp | 26.9%+0.6pp | 26.3%+0.9pp | 25.5%+1.2pp | 24.3%+1.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×0.0× | 1.5×0.0× | 1.5×0.0× | 1.5×0.0× | 1.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 9.1×+0.3× | 8.8×+0.6× | 8.2×+0.6× | 7.6×-0.1× | 7.7×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 2.4×0.0× | 2.4×0.0× | 2.4×0.0× | 2.3×0.0× | 2.3×+0.1× | |
| Net debt / EBITDA | 11.9×-0.2× | 12.1×-0.1× | 12.2×-0.3× | 12.6×-0.4× | 13×-0.1× | |
| Per Share | ||||||
| Book value per share | $151.37+0.8% | $150.20-0.3% | $150.61+0.1% | $150.52+0.2% | $150.29-0.3% | |
| Valuation | ||||||
| Market capitalization | $467.91B-0.9% | $472.07B+3.4% | $456.53B+0.2% | $455.62B+2.1% | $446.21B+0.3% | |
| Price / earnings | 99.5×-1.5× | 101×+1.3× | 99.8×-2.5× | 102.3×-2.2× | 104.5×-5.8× | |
| Price / sales | 13.3×-0.4× | 13.7×+0.2× | 13.5×-0.2× | 13.6×+0.1× | 13.5×-0.1× | |
| Price / book | 9.6×-0.1× | 9.8×+0.3× | 9.4×0.0× | 9.4×+0.2× | 9.2×+0.1× | |
| EV / EBITDA | 62.8×-1.5× | 64.2×+0.2× | 64×-2.1× | 66×-1.3× | 67.3×-1.5× | |
| Dividend yield | 12.5%+0.2pp | 12.3%-0.3pp | 12.6%0.0pp | 12.7%-0.3pp | 13%-0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Medtronic's profit margins?
- Medtronic (MDT) runs a 64.9% gross margin and a 17.0% operating margin, with a 13.0% net margin.
- Where do Medtronic's ratios come from?
- Every ratio is computed from Medtronic's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
